Menu
Log in
Forgot password

  • PO Box 450 Mawson ACT, 2607 Australia

  • 02 6260 4022

Member Alert: Publication of CMA position statement – Down-scheduling of Cannabidiol (CBD); AUST L(A) Data Protection: The Therapeutic Goods Amendment (2020 Measures No. 1) Bill 2020; End of Advertising Pre-approval process

15 May 2020 4:01 PM | Anonymous member (Administrator)

Today's Member Alert contains new industry updates in relation to:

- The publication of CMA's position statement on the down-scheduling of Cannabidiol (CBD)

- AUST L(A) Data protection: the Therapeutic Goods Amendment (2020 Measures No.1)Bill 2020.

- The upcoming end to the Advertising Pre-approval process.

Please click here for more details.

Copyright © 2019 Complementary Medicines Australia. All rights reserved.

Powered by Wild Apricot Membership Software